Fear of Cancer Recurrence: A Practical Guide for Clinicians
ByPhyllis Butow, MClinPsych, MPH, PhD,Louise Sharpe, PhD,Belinda Thewes, PhD,Jane Turner, PhD,Jemma Gilchrist, MClinPsych,Jane Beith, MBBS, PhD
Published: | Updated:
With increasing cancer survival, fear of cancer recurrence (FCR) is becoming a prominent clinical issue. FCR is prevalent, distressing, and long-lasting, and can negatively impact patients’ quality of life, use of health services, and adherence to follow-up recommendations. Novel targeted therapies may increase risk of FCR because of longer treatment duration and follow-up, increased prognostic precision, and omission of treatment based on genomic status.